Urokinase and tissue-type plasminogen activator stimulate human vascular smooth muscle cell migration

Fibrinolysis

Volumn 10, Issue SUPPL. 2, 1996, Pages 75-78

  Wijnberg, M J ^a   Nieuwenbroek, N M E ^a   Slomp, J ^a   Quax, P H A ^a   Verheijen, J H ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

CELL MIGRATION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0029905641     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80055-5     Document Type: Conference Paper

References (19)

1. Casscells W. Migration of smooth muscle and endothelial cells critical events in restenosis. Circulation 1992; 86: 723-729.
2. Vassalli JD. The urokinase receptor. Fibrinolysis 1994; 8 suppl.1: 172-181.
3. Danø K, Behrendt N, Brunner N, Ellis V, Ploug M, Pyke C. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8 suppl.1: 189-203.
4. Blasi F, Conese M, Moller LB,et al. The urokinase receptor: structure, regulation and inhibitor-mediated internalization. Fibrinolysis 1994; 8 suppl.1: 182-188.
5. Quax PHA, VanMuijen GNP, Weening-Verhoeff EJD, Lund LR, Danø K, Ruiter DJ, Verheijen JH. Metastatic behaviour of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-I inhibitor, and urokinase-mediated matrix degradation.
6. Ossowski L, Clunie G, Masucci MT, Blasi F. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J Cell Biol 1991; 115: 1107-1112.
7. Quax PHA, Boxman ILA, Van Kesteren CAM, Verheijen JH, Ponec M. Plasminogen activators are involved in keratinocyte and fibroblast migration in wounded cultures in vitro. Fibrinolysis. 1994; 8: 221-228.
8. Koolwijk P, Vanerck MGM, Devree WJA, Vermeer MA, Weich HA, Hanemaaijer R, Vanhinsbergh VWM. Cooperative effect of TNF alpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol 1996; 122: 673-684.
9. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res 1990; 67: 61-67.
10. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscl Thromb 1993; 13: 1218-1226.
11. Carmeliet P, Collen D. Evaluation of the plasminogen/plasmin system in transgenic mice. Fibrinolysis 1994; 8 suppl.1: 269-276.
12. Jaffe EA, Nachmann RL, Becker CG. Culture of endothelial cells derived from umbilical veins - Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756.
13. Depetro G, Copeta A, Barlati S. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp Cell Res 1994; 213: 286-294.
14. Rabbani SA, Mazar AP, Bernier SM, Haq M, Bolivar I, Henkin J, Goltzman D. Structural requirements for the growth factor activity of the aminoterminal domain of urokinase. J Biol Chem 1992; 267: 14151-14156.
15. Kirchheimer JC, Wojta J, Christ G, Hienert G, Binder BR. Mitogenic effect of urokinase on malignant and unaffected adjacent human renal cells. Carcinogenesis 1988; 9: 2121-2123.
16. Herbert JM, Lamarche I, Prabonnaud V, Dol F, Gauthier T. Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J Biol Chem 1994; 269: 3076-3080.
17. Okada SS, Tomaszewski JE, Barnathan ES. Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro. Exp Cell Res 1995; 217: 180-187.
18. Schleef RR, Birdwell CR. The effects of proteases on endothelial cell migration in vitro. Exp Cell Res 1982; 141: 503-508.
19. Padró T, Emeis JJ, Steins M, Schmid KW, Kienast J. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease. Arterioscler Thromb Vasc Biol 1995; 15: 893-902.